Problems in hemostasis during openheart surgery. III. Epsilon amino caproic acid as an inhibitor of plasminogen activator activity.
作者信息
GANS H, KRIVIT W
出版信息
Ann Surg. 1962 Feb;155(2):268-76. doi: 10.1097/00000658-196200000-00017.
Abstract
摘要
相似文献
1
Problems in hemostasis during openheart surgery. III. Epsilon amino caproic acid as an inhibitor of plasminogen activator activity.
Ann Surg. 1962 Feb;155(2):268-76. doi: 10.1097/00000658-196200000-00017.
2
Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator.
Ann Surg. 1961 Dec;154(6):915-24.
3
Hepatic and cardiac necrosis in a patient with prostatic carcinoma given 6-aminocaproic acid.
J Clin Pathol. 1963 Jan;16(1):61-4. doi: 10.1136/jcp.16.1.61.
4
The enhancement of chloroform-induced plasma proteolytic activity by epsilon aminocaproic acid.
J Exp Med. 1962 Apr 1;115(4):695-706. doi: 10.1084/jem.115.4.695.
5
Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid.
Ann Surg. 1961 Mar;153(3):383-93. doi: 10.1097/00000658-196103000-00008.
6
xi-Aminocaproic acid: an inhibitor of plasminogen activation.
J Biol Chem. 1959 Apr;234(4):832-7.
7
THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
Surg Gynecol Obstet. 1964 Jul;119:71-4.
8
Relative antiplasmin (antifibrinolysin) activity of omega-aminocarboxylic acids.
J Pharm Sci. 1962 Sep;51:912-3. doi: 10.1002/jps.2600510926.
9
[HEMORRHAGE, COAGULATION AND HEMOSTASIS IN "OPEN HEART" SURGERY PATIENTS. II. FAVORABLE INFLUENCE ON POSTOPERATIVE BLEEDING OF EPSILON-AMINOCAPROIC ACID INJECTION].
Ann Chir Thorac Cardiovasc. 1964 Jul;3:366-81.
10
[Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
Gazz Int Med Chir. 1962 Nov 30;66:2444-50.
引用本文的文献
1
Perioperative hyperfibrinolysis - physiology and pathophysiology.
Braz J Anesthesiol. 2021 Jan-Feb;71(1):65-75. doi: 10.1016/j.bjane.2020.12.007. Epub 2020 Dec 25.
2
High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy.
Case Rep Anesthesiol. 2016;2016:1630385. doi: 10.1155/2016/1630385. Epub 2016 Nov 10.
3
CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
Br Med J. 1965 Jun 26;1(5451):1632-5. doi: 10.1136/bmj.1.5451.1632.
4
CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
Ann Surg. 1963 Jul;158(1):117-25. doi: 10.1097/00000658-196307000-00021.
5
Antifibrinolytic therapy in cardiac surgery.
Tex Heart Inst J. 1995;22(3):211-5.
6
Thrombogenic properties of epsilon amino caproic acid.
Ann Surg. 1966 Feb;163(2):175-8. doi: 10.1097/00000658-196602000-00003.
7
Problems in hemostasis during open heart surgery. IX. Changes observed in the plasminogen-plasmin system and their significance for therapy.
Ann Surg. 1967 Dec;166(6):980-6. doi: 10.1097/00000658-196712000-00015.
本文引用的文献
1
The ROLE of the stomach in digestion.
Lancet. 1960 Feb 6;1(7119):322-4.
2
Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid.
Ann Surg. 1961 Mar;153(3):383-93. doi: 10.1097/00000658-196103000-00008.
3
xi-Aminocaproic acid: an inhibitor of plasminogen activation.
J Biol Chem. 1959 Apr;234(4):832-7.
Zotero 插件